Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection

clinical trial

Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT02135614

P6099clinical trial phasephase II clinical trialQ42824440
P17countryUnited States of AmericaQ30
BelgiumQ31
PolandQ36
ItalyQ38
NetherlandsQ55
FranceQ142
United KingdomQ145
AustraliaQ408
New ZealandQ664
IsraelQ801
P582end time2017-03-27
P2899minimum age18
P1132number of participants189
P6153research siteUniversity of WashingtonQ219563
Tel Aviv UniversityQ319239
Soonchunhyang UniversityQ484622
Monash UniversityQ598841
NewYork–Presbyterian HospitalQ975653
Griffith UniversityQ1202292
Rabin Medical CenterQ2071553
hôpital FochQ3145155
Tenon HospitalQ3145241
Seoul National University HospitalQ4403855
Asan Medical CenterQ4803501
Henry Ford Health SystemQ5721418
Northwestern Memorial HospitalQ7060339
Waikato HospitalQ7959998
Westmead HospitalQ7989074
Rochester General HospitalQ28229048
P580start time2014-06-09
P8363study typeinterventional studyQ78089383
P1476titleA Phase 2b, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of GS-5806 in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection

Search more.